Инструмент | Доходность к погашению % | Цена % | Купонная доходность % | Срок погашения | Задолженность | Номинал | Мин. деноминация | Эмитент |
---|---|---|---|---|---|---|---|---|
NNVS5894401Novartis Capital Corp. 4.7% 18-SEP-2054 | 4,80% | 98,26% | 4,70% | 2054-09-18 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
UUS66989HAH1NOVARTIS CAPITAL 14/44 | 4,77% | 95,01% | 4,40% | 2044-05-06 | 1,85 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
XXPNDNOVARTIS CAPITAL 15/45 | 4,74% | 89,59% | 4,00% | 2045-11-20 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
UUS66989HAS7NOVARTIS CAP 20/50 | 4,62% | 69,67% | 2,75% | 2050-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS3904288Novartis Capital Corp. 3.7% 21-SEP-2042 | 4,48% | 90,00% | 3,70% | 2042-09-21 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894400Novartis Capital Corp. 4.2% 18-SEP-2034 | 4,35% | 98,73% | 4,20% | 2034-09-18 | 1,1 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894399Novartis Capital Corp. 4.0% 18-SEP-2031 | 4,12% | 99,30% | 4,00% | 2031-09-18 | 850 M USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
XXPNCNOVARTIS CAPITAL 15/25 | 4,08% | 98,80% | 3,00% | 2025-11-20 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
UUS66989HAR9NOVARTIS CAP 20/30 | 3,95% | 90,81% | 2,20% | 2030-08-14 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894398Novartis Capital Corp. 3.8% 18-SEP-2029 | 3,92% | 99,45% | 3,80% | 2029-09-18 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
UUS66989HAN8NOVARTIS CAPITAL 17/27 | 3,84% | 98,15% | 3,10% | 2027-05-17 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS4950565Novartis Capital Corp. 2.0% 14-FEB-2027 | 3,72% | 96,08% | 2,00% | 2027-02-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
XXS176904160NOVARTIS FIN. 18/38 | 2,96% | 85,50% | 1,70% | 2038-08-14 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
UUS66989HAP3NOVARTIS CAP 20/25 | 2,84% | 98,93% | 1,75% | 2025-02-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
XXS176904119NOVARTIS FIN. 18/30 | 2,61% | 93,25% | 1,38% | 2030-08-14 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS223599621NOVARTIS FI. 20/28 | 2,55% | 90,34% | 0,00% | 2028-09-23 | 1,85 B EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS113472979NOVARTIS FIN. 14/26 | 2,39% | 98,43% | 1,63% | 2026-11-09 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
NNOJANOVARTIS FIN. 17/27 | 2,39% | 96,34% | 1,13% | 2027-09-30 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS149282548NOVARTIS FIN. 16/28 | 2,31% | 93,58% | 0,63% | 2028-09-20 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
CH1353257830NOVARTIS INC 2024-18.06.40 REG S | 1,14% | 110,30% | 1,85% | 2040-06-18 | 280 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |
CH1353257848NOVARTIS INC 2024-18.06.49 REG S | 1,14% | 115,49% | 1,85% | 2049-06-18 | 190 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |
CH27019100NOVARTIS AG 15-35 | 1,05% | 100,03% | 1,05% | 2035-05-11 | 325 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |
CH135325782NOVARTIS 24/34 | 1,01% | 106,83% | 1,75% | 2034-06-16 | 645 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |
CH1353257814NOVARTIS INC 2024-18.06.31 REG S | 0,94% | 104,61% | 1,65% | 2031-06-18 | 435 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |
NOTCNOVARTIS AG 15-29 | 0,80% | 99,10% | 0,63% | 2029-11-13 | 550 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |
CH135325780NOVARTIS 24/27 | 0,77% | 102,24% | 1,60% | 2027-06-18 | 650 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |
NOTBNOVARTIS AG 15-25 | 0,64% | 99,61% | 0,25% | 2025-05-13 | 500 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG |